GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2022-05-27 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-26 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-25 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-24 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-23 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-20 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-19 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-18 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-17 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-16 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-13 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-12 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-11 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-10 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-09 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-06 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-05 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-04 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-03 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-05-02 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-29 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-28 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-27 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-26 $0.000001 $0.000001 $0.000001 $0.000001 0
2022-04-25 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT